Intracellular and extracellular visfatin has been associated with cancer development by promoting cellular growth, angiogenesis, and metastasis through the MAPK, AKT, STAT3, and NF-κB/Notch1 pathways in macrophages, human endothelial cells, and breast cancer cells (Table 1). The gene discussed is STAT3; the disease is cancer.